Role of mineralocorticoid action in the brain in salt-sensitive hypertension

被引:28
作者
Oki, Kenji [1 ,2 ]
Gomez-Sanchez, Elise P. [1 ,2 ]
Gomez-Sanchez, Celso E. [1 ,2 ]
机构
[1] Univ Mississippi, Med Ctr, Div Endocrinol, Jackson, MS 39216 USA
[2] Univ Mississippi, Med Ctr, GV Sonny Montgomery VA Med Ctr, Res Serv, Jackson, MS 39216 USA
来源
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 2012年 / 39卷 / 01期
基金
美国国家卫生研究院;
关键词
aldosterone; central nervous system; salt-sensitive hypertension; CENTRAL-NERVOUS-SYSTEM; BLOOD-PRESSURE; RAT-BRAIN; RECEPTOR ANTAGONISM; SODIUM-CHANNELS; HEART-FAILURE; INTRACEREBROVENTRICULAR INFUSION; VASCULAR INFLAMMATION; DEHYDROGENASE TYPE-2; SYMPATHETIC DRIVE;
D O I
10.1111/j.1440-1681.2011.05538.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The mechanisms by which excessive salt causes hypertension involve more than retention of sodium and water by the kidneys and are far from clear. Mineralocorticoids act centrally to increase salt appetite, sympathetic drive and vasopressin release, resulting in hypertension that is prevented by the central infusion of mineralocorticoid receptor (MR) antagonists. The MR has similar affinity for aldosterone and the glucocorticoids corticosterone or cortisol. Specificity is conferred in transport epithelia by the colocalization of the MR with 11 beta-hydroxysteroid dehydrogenase Type 2. Coexpression also occurs in some neurons, notably those of the nucleus tractus solitarius that are activated by sodium depletion and aldosterone and mediate salt-seeking behaviour. 2. The salt-induced hypertension of the Dahl salt-sensitive rat is mitigated by the central infusion of a mineralocorticoid antagonist even though circulating aldosterone is normal or reduced in salt-sensitive (SS). Contrary to reports that salt appetite in the Dahl salt-sensitive rat is depressed, we found that it is increased compared with that in Spraque-Dawley rats. 3. Extra-adrenal aldosterone synthesis in the brain occurs in minute amounts that could only be relevant locally. Expression of aldosterone synthase mRNA and aldosterone concentrations in the brain of Dahl salt-sensitive rats are increased compared with Spraque-Dawley rats. The central infusion of inhibitors of aldosterone synthesis lowers salt-induced hypertension in the Dahl salt-sensitive rat, suggesting a role for excessive Dahl salt-sensitive synthesis in the brain. Brain MR, particularly those in the paraventricular nuclei, regulate inflammatory processes that are exacerbated by sodium and lead to cardiovascular dysfunction.
引用
收藏
页码:90 / 95
页数:6
相关论文
共 79 条
[1]   TYPE-I CORTICOSTEROID RECEPTOR-LIKE IMMUNOREACTIVITY IN THE RAT CNS - DISTRIBUTION AND REGULATION BY CORTICOSTEROIDS [J].
AHIMA, R ;
KROZOWSKI, Z ;
HARLAN, R .
JOURNAL OF COMPARATIVE NEUROLOGY, 1991, 313 (03) :522-538
[2]   Distribution of epithelial sodium channels and mineralocorticoid receptors in cardiovascular regulatory centers in rat brain [J].
Amin, MS ;
Wang, HW ;
Reza, E ;
Whitman, SC ;
Tuana, BS ;
Leenen, FHH .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2005, 289 (06) :R1787-R1797
[3]   LOCALIZATION OF ALDOSTERONE AND CORTICOSTERONE IN THE CENTRAL NERVOUS-SYSTEM, ASSESSED BY QUANTITATIVE AUTORADIOGRAPHY [J].
BIRMINGHAM, MK ;
SAR, M ;
STUMPF, WE .
NEUROCHEMICAL RESEARCH, 1984, 9 (03) :333-350
[4]  
BRODY MJ, 1978, CIRC RES, V43, pI2
[5]  
BRODY MJ, 1988, CLIN PHYSIOL BIOCH, V6, P230
[6]  
BRODY MJ, 1991, HYPERTENSION, V18, pS7
[7]   Aldosterone and vascular inflammation [J].
Brown, Nancy J. .
HYPERTENSION, 2008, 51 (02) :161-167
[8]   BLOOD-PRESSURE-LOWERING EFFECT OF AN ORALLY-ACTIVE VASOPRESSIN V(1) RECEPTOR ANTAGONIST IN MINERALOCORTICOID HYPERTENSION IN THE RAT [J].
BURRELL, LM ;
PHILLIPS, PA ;
STEPHENSON, JM ;
RISVANIS, J ;
ROLLS, KA ;
JOHNSTON, CI .
HYPERTENSION, 1994, 23 (06) :737-743
[9]   ATTENUATION OF GENETIC-HYPERTENSION AFTER SHORT-TERM VASOPRESSIN V1A RECEPTOR ANTAGONISM [J].
BURRELL, LM ;
PHILLIPS, PA ;
RISVANIS, J ;
ALDRED, KL ;
HUTCHINS, AM ;
JOHNSTON, CI .
HYPERTENSION, 1995, 26 (05) :828-834
[10]   Neurosteroids: Biosynthesis and function of these novel neuromodulators [J].
Compagnone, NA ;
Mellon, SH .
FRONTIERS IN NEUROENDOCRINOLOGY, 2000, 21 (01) :1-56